International Stem Cell Corp. (ISCO) Schedules Conference Call to Discuss Positive Study Data of Parkinson’s Disease
International Stem Cell Corp., a California-based biotechnology company focused on therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that it will be hosting a conference call tomorrow morning to discuss results of its Parkinson’s Disease study that it presented at the American Academy of Neurology 65th Annual Meeting (AAN) this week. Dr. Ruslan Semechkin, Vice President of Research and Development for ISCO and Dr. Simon Craw, Executive Vice President, will host the call.
Date: March 22, 2013
Time: 11:00 a.m. ET
Conference Line (U.S.): 1-888-846-5003
International Dial-In: 1-480-629-9856
Conference ID: 4610097
The stem cell company advises interested parties to join at least 10 minutes before the start time. A supplementary slide deck is available at the newsroom section of ISCO’s website at: www.internationalstemcell.com/Company_Presentation.
A playback of the call will be available shortly after the call’s conclusion. To listen, call 1-877-870-5176 within the United States or 1-858-384-5517 when calling internationally. When promoted, use the following replay pin number: 4610097.
For more information, visit www.internationalstemcell.com
Let us hear your thoughts: International Stem Cell Corp. Message Board